![Head‐to‐head trials of systemic psoriasis therapies: a systematic review of study design and maximum acceptable treatment differences - Wan - 2019 - Journal of the European Academy of Dermatology and Venereology - Head‐to‐head trials of systemic psoriasis therapies: a systematic review of study design and maximum acceptable treatment differences - Wan - 2019 - Journal of the European Academy of Dermatology and Venereology -](https://onlinelibrary.wiley.com/cms/asset/f9bee270-494d-47c3-ab8a-bfa9cba8a948/jdv15174-fig-0002-m.jpg)
Head‐to‐head trials of systemic psoriasis therapies: a systematic review of study design and maximum acceptable treatment differences - Wan - 2019 - Journal of the European Academy of Dermatology and Venereology -
![Systemic Psoriasis Therapies and Comorbid Disease in Patients with Psoriasis: A Review of Potential Risks and Benefits – JCAD | The Journal of Clinical and Aesthetic Dermatology Systemic Psoriasis Therapies and Comorbid Disease in Patients with Psoriasis: A Review of Potential Risks and Benefits – JCAD | The Journal of Clinical and Aesthetic Dermatology](https://jcadonline.com/wp-content/uploads/JCADJune2019GoldenbergTable1.gif)
Systemic Psoriasis Therapies and Comorbid Disease in Patients with Psoriasis: A Review of Potential Risks and Benefits – JCAD | The Journal of Clinical and Aesthetic Dermatology
![Psychiatric adverse events during treatment with brodalumab: Analysis of psoriasis clinical trials - Journal of the American Academy of Dermatology Psychiatric adverse events during treatment with brodalumab: Analysis of psoriasis clinical trials - Journal of the American Academy of Dermatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/dcf78377-dd8a-4a53-b4a6-0c34b86e294a/gr1.jpg)